| V06202 | |
|
|
|
| 询价 | |
|
|
|
|
|
|
| 联系我们 | |
Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease. |
CEA Antibody (RC67), mAb, Mouse
GenScript can customize this product per customer's request including product size, buffer components, etc.
| Subclass | IgG1 |
| Host Species | Mouse |
| Conjugation | Unconjugated |
| Antigen Species | Human |
| Production | Cultured in vitro under conditions free from animal-derived components |
| Purification | Protein A/G affinity column |
| Formulation |
1) PBS, pH 7.4, containing 0.03% Proclin 300 2) 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 * *: For new batch since 09/01/2018, please refer to COA. |
| Concentration | ≥2mg/ml |
| Clone ID | RC67 |
| Recommended pairs |
Sandwich immunoassay (Capture-Detection):
RC66–RC67 |
| Storage | For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. |
| ELISA |
| Target Background | Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease. |
